Fluvoxamine Attenuates Panic Induced by 35% CO2 Challenge

Article Abstract

Background: The authors investigated whether 6 weeks of treatment with fluvoxamine would decrease the anxiogenic response to the 35% CO2 challenge in 11 patients with DSM-IIIR panic disorder with agoraphobia.

Method: The patients underwent a 35% CO2 challenge at baseline and again after 6 weeks of fluvoxamine treatment.

Results: The anxiogenic effect of CO2 was significantly (p < .05) reduced during fluvoxamine treatment.

Conclusion: The results suggest a relationship between the anxiogenic effect of CO2 and the therapeutic effect of fluvoxamine.

Volume: 57

Quick Links: Anxiety , Panic Disorder

Continue Reading…

Subscribe to read the entire article


Buy this Article as a PDF